Research identifies how cancer cells cheat death

Research led by David Litchfield of The University of Western Ontario has identified how biochemical pathways can be "rewired" in cancer cells to allow these cells to ignore signals that should normally trigger their death. It's one way that cancer cells may become resistant to therapy. The findings are now published in Science Signaling.

"This work focused on understanding how cancer cells acquire a selective survival advantage, allowing them to avoid apoptosis, the process required for normal cell turnover and chemically-induced cell death" says Litchfield, Chair of the Department of Biochemistry and Professor in the Department of Oncology at the Schulich School of Medicine & Dentistry. "Our work also provides encouragement for the development of novel therapeutic approaches that would prevent - or neutralize - this 'rewiring' to make sure that respond to treatment."

More information: http://stke.sciencemag.org/cgi/content/full/sigtrans;4/172/ra30

Related Stories

Why cancer cells just won't die (w/ Video)

date Dec 09, 2009

When cells experience DNA damage, they'll try to repair it. But if that fails, the damaged cells are supposed to self-destruct, a process called apoptosis. A cancer researcher at Robarts Research Institute at The University ...

Potential new therapeutic molecular target to fight cancer

date Nov 01, 2007

Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.

An Achilles heel in cancer cells

date Dec 08, 2008

A protein that shields tumor cells from cell death and exerts resistance to chemotherapy has an Achilles heel, a vulnerability that can be exploited to target and kill the very tumor cells it usually protects, researchers ...

Recommended for you

Mammography benefits overestimated, review says

date 5 hours ago

An in-depth review of randomised trials on screening for breast, colorectal, cervical, prostate and lung cancers, published in the Journal of the Royal Society of Medicine, shows that the benefits of mammographic screening are li ...

Extended-field IMRT does not increase duodenal toxicity risk

date 7 hours ago

A study of women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.